# OnCo record oncotype-dx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/oncotype-dx/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "oncotype-dx" ;
  schema:name "Oncotype DX"@en ;
  schema:description "A 21-gene test that tells most women with early hormone-positive breast cancer whether they can safely skip chemotherapy."@en ;
  schema:url <https://onco.cc/drugs/oncotype-dx/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1804710>, <https://www.nice.org.uk/guidance/dg34> ;
  onco:status "established" ;
  onco:modality "Gene-expression prognostic/predictive assay" ;
  onco:related <https://onco.cc/drugs/mammaprint/>, <https://onco.cc/drugs/prosigna/>, <https://onco.cc/drugs/endopredict/>, <https://onco.cc/pairings/genomic-assay-to-chemo-omission/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/gene-expression-prognostic-assays/> ;
  onco:companies <https://onco.cc/companies/exact-sciences/> ;
  onco:trials <https://onco.cc/trials/tailorx/>, <https://onco.cc/trials/rxponder/> .